Pharmacotherapy of tension-type headache (TTH)

被引:7
作者
Lenaerts, Marc E. [1 ]
机构
[1] Univ Calif Davis, Mercy Med Grp, Sacramento, CA 95816 USA
关键词
headache; pharmacotherapy; tension-type; treatment; TOXIN TYPE-A; PRESSURE PAIN THRESHOLDS; LONG-TERM EFFICACY; DOUBLE-BLIND; BOTULINUM-TOXIN; PROPHYLACTIC TREATMENT; NAPROXEN SODIUM; PLACEBO; AMITRIPTYLINE; ACETAMINOPHEN;
D O I
10.1517/14656560902942046
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Tension-type headache (TTH) is a highly prevalent condition, yet it requires less medical attention than migraine, mostly because the pain and disability burden are milder. Methods: Proper diagnosis is a paramount step in therapeutic adequacy. It comes from careful history, thorough physical examination and use of ancillary investigations when appropriate to rule out underlying causes of secondary headaches that could mimic TTH, as there is no biological marker for the condition. Results: Research in TTH is insufficient Thus, pathophysiologic understanding and therapeutic innovations are lagging. In that context, the clinicians should not be surprised by the paucity of pharmacotherapeutic options. Conclusion: in this article, we review the existing literature on medications and make practical recommendations based on the evidence of their efficacy. We review both abortive and prophylactic medications (such as tricyclic antidepressants and non-steroidal anti-inflammatory drugs, respectively). Both are used for chronic TTH and abortive medications only for infrequent episodic TTH (ETTH). As far as frequent ETTH, abortive medications are used and prophylactic medications often but not systematically. We comment and advise on general therapeutic principles of TTH management.
引用
收藏
页码:1261 / 1271
页数:11
相关论文
共 100 条
  • [1] Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting
    Adelman, LC
    Adelman, JU
    Von Seggern, R
    Mannix, LK
    [J]. HEADACHE, 2000, 40 (07): : 572 - 580
  • [2] Tension headaches and muscle tension: is there a role for magnesium?
    Altura, BM
    Altura, BT
    [J]. MEDICAL HYPOTHESES, 2001, 57 (06) : 705 - 713
  • [3] A comparison of selected osteopathic treatment and relaxation for tension-type headaches
    Anderson, Rosemary E.
    Seniscal, Caryn
    [J]. HEADACHE, 2006, 46 (08): : 1273 - 1280
  • [4] Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial
    Ashina, M
    Lassen, LH
    Bendtsen, L
    Jensen, R
    Olesen, J
    [J]. LANCET, 1999, 353 (9149) : 287 - 289
  • [5] Ashina Messoud, 2007, CNS & Neurological Disorders-Drug Targets, V6, P238
  • [6] Ashina Messoud, 2002, Expert Opin Pharmacother, V3, P395, DOI 10.1517/14656566.3.4.395
  • [7] Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition
    Ashina, S
    Bendtsen, L
    Jensen, R
    [J]. PAIN, 2004, 108 (1-2) : 108 - 114
  • [8] Current and potential future drug therapies for tension-type headache
    Sait Ashina
    Messoud Ashina
    [J]. Current Pain and Headache Reports, 2003, 7 (6) : 466 - 474
  • [9] Decreased pain detection and tolerance thresholds in chronic tension-type headache
    Bendtsen, L
    Jensen, R
    Olesen, J
    [J]. ARCHIVES OF NEUROLOGY, 1996, 53 (04) : 373 - 376
  • [10] Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache
    Bendtsen, L
    Jensen, R
    [J]. CEPHALALGIA, 2000, 20 (06) : 603 - 610